Tecovirimat — Active Pharmaceutical Ingredient

Tecovirimat is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: SOLUTION, CAPSULE. Routes: INTRAVENOUS, ORAL.

This content is for informational purposes only. Always consult a healthcare professional.

Tecovirimat (1 brand name, 2 dosage forms, 2 routes)

Available dosage forms: SOLUTION, CAPSULE.

Routes of administration: INTRAVENOUS, ORAL.

Brand Names

  • TPOXX

Contraindications

TPOXX Capsules: None. TPOXX Injection: The excipient hydroxypropyl-β-cyclodextrin is eliminated through glomerular filtration. Therefore, TPOXX Injection is contraindicated in patients with severe renal impairment (defined as creatinine clearance below 30 mL/min) [see Warnings and Precautions ( 5.2) and Use in Specific Populations ( 8.6)] .

Mechanism of Action

Tecovirimat is an antiviral drug against variola (smallpox) virus [see Microbiology ( 12.4)] .

Overdosage

There is no clinical experience with overdosage of TPOXX. In case of overdosage, monitor patients for any signs or symptoms of adverse effects. Hemodialysis will not significantly remove TPOXX in overdosed patients.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.